Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-166113
Filing Date
2017-05-10
Accepted
2017-05-10 17:22:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A d380004ds3a.htm S-3/A 440769
2 EX-23.1 d380004dex231.htm EX-23.1 1640
3 GRAPHIC g380004g0425153600926.jpg GRAPHIC 2869
4 GRAPHIC g380004g0425153601082.jpg GRAPHIC 2926
  Complete submission text file 0001193125-17-166113.txt   451898
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-217459 | Film No.: 17831606
SIC: 2835 In Vitro & In Vivo Diagnostic Substances